Get started

Gapup

Botanix: Strength to StrengthBotanix Pharmaceuticals Ltd (ASX:BOT) is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. Bullish Outlook: - Trending Bullish within Upward Channel - Double Bottom off Support - RSI not Overbought - TB Fib Targets Achievable - Positive news should see this continue trend Trading. "DISCLAIMER: NO ADVICE. The information presented here is general in nature and is for education purposes only. Nothing should be considered to be advice. You should consult with an appropriate professional for specific advice tailored to your situation."
ASX:BOTLong
by Trader_Johnni
Potential Gap fill to take us down 20%Price looks extended into resistance, after a huge gap up we saw a huge spike in volume. Now it appears that the sell side volume is taking over as we have not had many green days since we got here and the MACD has given us our bearish crossover. The weekly does not make make it look any better as we seem to have a confirmed Gravestone Doji on our weekly chart: I believe we could see a huge drop in the coming days possibly to fill the gap below.
AShort
by RizeSenpai
DIS 12/21/2020 LongDIS gapped up on heavy volume over a significant level that it was bumping up against & has spent six days digesting these higher prices. I bought a half-sized position on Monday (12/21/20) when the market gapped lower due to a new COVID strain mutation in the U.K. I believe that the market is over COVID & has been for some time. Unless there is a negative development on the vaccine front, Pumpin' Powell is going to be able to continue inflating the asset bubble. The DIS pullback also coincided nicely with a bounce off of the 9-day EMA. My initial stop is below the low of the gap-up day. I'm looking to add larger size on a break of Monday's highs circa $172. I would also be willing to add on a false break & quick reclaim of Monday's lows, at which point I would move stops up to just below the false break.
NYSE:DISLong
by apaqu
ETHUSD to see an uptrend(4Hr) | Gap up expected | MACD BullishMarket in last 24hrs ETHUSD saw a slight uptrend with price started to ride the upper band Price volatility was very high. The market moved ~10.69% between $593.74 and $536.38 Today’s Trend analysis ETHUSD expected to see an uptrend with the price riding the upper band with gap up in price expected with Bollinger band expanding Price at the time of publishing: $586.16 ETH’s market cap: $66.6 Billion Oscillator indicators are mostly neutral. RSI at 65 Moving average indicators are suggesting an uptrend. Ichimoku Cloud is neutral Volume indicators observed a change from decreasing with an increase in price to an increase in volume with an increase in price Price expected to see an uptrend with the price riding the upper band with gap up in price expected with Bollinger band expanding. Most of the Oscillator indicators are neutral. MACD line moving above the signal line, with the histogram size increasing in the positive region suggesting bullish bias. RSI at 65, in the neutral region above the midline. CCI with a value of around 147 in the overbought region. Another interesting point to notice here is that the volume observed a change from decreasing with an increase in price to an increase in volume with an increase in price indicating a shift from sellers to buyers. ---------------------------------------------------------------------------------------- The analysis is based on signals from 28 technical indicators, out of which 17 are moving averages and the remaining 11 are oscillators. These indicator values are calculated using 4Hr candles. Note: Above analysis would hold true if we do not encounter a sudden jump in trade volume . ---------------------------------------------------------------------------------------- If you find the analysis useful, please like and share our ideas with the community as well as follow to stay updated with new ideas! - Mudrex
COINBASE:ETHUSDLong
by Mudrex
12
SELB Lots Of Technical Levels To Look AtSELB filled that gap down from its data miss a few weeks back and now testing a pretty consistent level of previous support/resistance. "Selecta and IGAN Biosciences entered into a research license and option agreement to study Selecta’s ImmTOR™ immune tolerance platform in combination with IGAN’s immunoglobulin A protease for the treatment of IgA Nephropathy. We then saw the company and AskBio receive FDA Rare Pediatric Disease Designation for their gene therapy for methylmalonic Acidemia; several key milestones in a very short time span...Director Timothy Springer remains bullish on the company. He picked up another 3.6 million shares from October 21-23 at prices ranging from $2.4994 to $2.7147. Springer has been buying up shares for weeks. This latest round brings his position size to over 11 million shares in the company so far." Original Quote Source: 5 Biotech Penny Stocks To Watch With Recent & Upcoming Events
S
by PennyStocks101
1
$SPCE How To Best Position Yourself For Future DevelopmentsThis is a follow-up post from my previous $SPCE analysis on October 4th titled "$SPCE Love Space Travel, But You May Want To Wait Before Buying". Technical Analysis In my previous post, when $SPCE was priced at $20.77 before the moon towards the October 20th's Highs of $24.36, I talked about how at that point in time, $SPCE had 2 unfilled gaps at $24.02 and $16.43 respective, despite having a history of closing any of its gaps. Within that post, I also gave 2 possible scenarios that I foresaw would occur leading up to the October 22nd's window opening for Virgin Galactic's next crewed spaceflight test. If you are interested to see what exactly my previous analysis was about, you can refer to my previous post which I have linked down below in the 'Related Ideas' section. Update 1: Since the post on October 4th, we saw $SPCE prices staying above the Symmetrical Triangle chart pattern after breaking out of it and re-testing the Slope of Lower Highs on October 13th. After rejecting the Slope of Lower Highs, it continued bulling and eventually filled 1 of the 2 unfilled gaps at $24.02 on October 20th. However, after filling the gap and reaching the Highs of $24.36, we saw an immediate rejection within the same 4H candle, creating a Shooting Star candlestick pattern. Later on during the session, we saw prices rejecting all the way down and closing at $20.44 for the day. Update 2: What caused this huge 16% decline from the peak of $24.36? There are 2 reasons for this. The first reason is a technical one based on what I have mentioned earlier. After closing the $24.02 gap, $SPCE entered into a strong resistance zone of $24.26 to $24.85. On top of this, because of the meteoric rise, a Regular Bearish Divergence was also created. These technical factors combined created a retracement cum rejection from the strong resistance zone. Update 3: However, based on this factor alone, it does not justify a 16% decline from the peak. This brings me to my 2nd reason which is short-seller Jim Chanos of Kynikos Associates' comment on the space sector. If you aren't aware of what happened, at an investor conference, Chanos expressed his bullishness on the space sector but later retracted his statement by saying that he was joking. This, combined with the technical factor I mentioned earlier, created a 16% decline from the peak of $24.36. Entries, Price Targets, Stop Losses Because of the highly speculative nature of $SPCE plays at this stage due to so many uncertainties surrounding it and so many things that can go wrong, I can't give an exact price target or stop loss at this juncture. But what I can say is that, if something does go wrong, even the most minute incident that is unfavorable for $SPCE, it is almost certain that we will see $SPCE back in the $16.43 range to close the last unfilled gap. What I can also say is that if you want to trade or invest in $SPCE - don't go all-in yet . The approach to take is to have a small enough position in $SPCE so that you feel that you have some skin in the game but not so much position such that even if $SPCE falls to the $14.00 to $16.00 range, you can still feel emotionless. Personally, I have taken this approach as well, where I have an entry at $20.91 and is mentally prepared to stay emotionless for both a meteoric crash towards $14.00 as well as a meteoric rise towards $30.00. Disclaimer I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor. All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment, or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies. I will not and cannot be held liable for any actions you take as a result of anything you read here. Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise. If this post has helped you out in making your investment/trading decision, give it a huge thumbs up, and follow for more updates regarding this ticker symbol!
NYSE:SPCELong
by UnknownUnicorn6361804
6
$SPCE Love Space Travel, But You May Want To Wait Before BuyingTechnical Analysis Currently, $SPCE is respecting a Symmetrical Triangle chart pattern, where neither the buyers nor the sellers are pushing the price far enough to form a clear trend. As of 4/10/2020, the price closed at $20.77, at the slope of lower highs. Even though I believe that $SPCE has explosive long-term growth potential, assuming that the company is able to reach the stage where they are able to successfully follow their timeline and fly Sir Richard Branson to space , based on the technical factors and risk-reward ratio, I strongly advise against entries at the current price point until further confirmation signals. The reason that $SPCE was able to soar to the $20 mark in such a short period of time from the recent $16 range is due to a gap up driven by BofA Securities upgrading $SPCE to "buy" with a price target of $35.00. However, as you can see from my chart, historically, gaps are almost always filled - rather quickly in fact. There are 2 exceptions where gaps are not filled yet, namely the 3/8/2020 gap down from $24.02 to $21.75 and the 25/9/2020 gap up from $16.43 to $18.29. With the bearish market outlook currently due to POTUS contracting COVID-19 acting as a catalyst and the Symmetrical Triangle acting as a resistance to push the price down, the likelihood that we will revisit $16.43 to close the gap is very plausible. Furthermore, fundamentally, there has been no change to the company yet - at least until 22/10/2020 . Thus, with the price being purely driven by BofA, the $20.00 price may not be sustainable in the short-term. Entries, Price Targets, Stop Losses The best price for entry would either be at the $16.43 range or if the price breaks above the Symmetrical Triangle, retrace back to the slope of lower lows or the $21.00 to $21.58 Support and Resistance Zone, and holds above it. For my price target prior to 22/10/2020, depending on whether you are bullish or bearish on $SPCE short-term, it will either be $24.02 or $16.43. Since I am bearish short-term but bullish long-term, I am leaning more towards $16.43 prior to 22/10/2020. As for my price target beyond 22/10/2020, it will depend on whether the suborbital test flight is successful. I will do an update of this post in the future once $SPCE announces the result. As for my stop-losses, bulls stop-loss will be at $16.43 while bears stop-loss will be at $24.02. As you can see, if you were to enter into a new position at the current price-point, bulls have an upside gain of $3.25 per share with a downside risk of $4.34 while it is vice-versa for the bears. Thus, the risk-reward is really not that worth it. Even if you are a long-term investor, $SPCE is still at a highly speculative stage. The best-case scenario in the event of a test-flight delay or crash is a plunge towards $16.43. Although if everything goes as planned, $20.77 would look like a steal for you in the future. But if you have the conviction, go for it. It is a really high risk, high reward play for investors, and it will take conviction to stay in the trade. Disclaimer I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor. All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment, or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies. I will not and cannot be held liable for any actions you take as a result of anything you read here. Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise. If this post has helped you out in making your investment/trading decision, give it a huge thumbs up, and follow for more updates regarding this ticker symbol!
NYSE:SPCELong
by UnknownUnicorn6361804
Bullish reversal with a gap to fill aboveUpdated from the earlier idea with adjusted fibs. Where the extension from March to recent monthly highs aligned, I used that fib as marked entry. Solid uptrend established Still oversold on the daily Entry near the fib especially after a successful backtest as support would be a solid entry. First gap comes from a large space in which there was no candle closures since the gap down; this may not be a technical gap down but may have an impact on price action. The true gap is small and marked within. Either way, this should make a nice move upward through that space.
NYSE:SELong
by SpinTrades
NASDAQ: Daily Next Support $9838 and $9018There is a 9% price drop until the next support is hit. Most recently on Friday the support at $10747 was hit and there was a slight bounce. The expectation is now some sideways slightly down action. If there is a 50% retractment to 11k it would meet expectations. The green lines on the chart is the daily gap up and shows support. The next support is at the minor high of of $9838, which comes right around a nice $10,000 number. "Nice" numbers are more psychological and they provide support and resistance. If you see there was a nice gap up at $7,000 and from there there NASDAQ never look back till 12,000. Enjoy all the Support lines. :) P.S. This analysis was mainly done in conjunction with my podcast where I explain Support and Resistance using Gap Ups and Different Time Frames Below is the hourly Chart Analysis:
NASDAQ:IXICShort
by HaleyZhao
BOT Ready to GAP(ASX:BOT) Botanix Pharmaceuticals Limited is a clinical stage synthetic cannabinoid company based in Perth (Australia) and Philadelphia (USA) committed to the development of pharmaceutical products that are underpinned by science and supported by well-controlled randomised clinical trials. Technicals: Shaping up to GAP - Ascending Triangle Pattern - 10/20 MA Golden Cross - RSI Bullish + Above the 50 - MACD Bullish and Spread - Fractal Target 1 lining up with Previou EQ and 0.236 Fib Retracement @ 0.081 - Fractal Target 2 close to another Resistance level @ 0.095 - GAPs Present @ 0.14 - 0.234, 0.027 - 0.029, 0.034 - 0.037 - "Golden Pocket" 0.5-.618 Fib Retracement sitting within 0.14 - 0.234 GAP - Stop loose @ 0.042 Fundamentals: Undervalued, Debt Free, +$20 Million Cash - Multiple Phase 2 Clinical Trials underway with FDA Meetings successful for there Cannabinoid Products. - Antimicrobial Study Phase 2 to be completed 4th Quarter 2020 - World Class Board of Directors & Advisors with Key Experience in Management, Research & Development, FDA Approvals, Pharmaceuticals, Therapeuticals - Debt Free with $24.6 Million in Cash and Investments - Total Liabilities of $1.37 Million covered by $24.7 Million in Assets Technically and Fundamentally this is shaping up to be a great Trade & Long term Investment. My only Concern is how the effects of COVD19 will weigh on the Therapeutic/ Pharmaceutical Industry. Definitely a Sector and Company to keep watch of. Setups/Strategies should be based on Individual Trade/ Risk Management Plan These Ideas are NOT 'Financial Advice'!. Scenarios are based off a mixture of TA and Fundamentals current at the time. All IMO GLTAH. Happy Hunting!!!
ASX:BOTLong
by Trader_Johnni
7